In-House Versus Outsource: A Decision-Making Guide

Biopharmaceutical companies are increasingly looking for new strategies to bring biologics to market quickly and cost effectively. Companies must carefully assess whether their in-house teams can truly deliver everything a project needs to be successful – from accurate supply forecasting to successful IND submission to meeting aggressive timelines. In doing so, biopharmaceutical executives must consider how outsourcing fits into their development and production strategy, as well as how to select the best CDMO partner for their business.

Here’s a step-by-step guide for biopharmaceutical executives to use when considering if outsourcing fits into their development and production strategy, as well as how to select the best CDMO partner for their business.

Max Character Limit 45

Max Character Limit 45

Max Character Limit 460 - error sit voluptatem accusantium doloremque laudantium, totam rem aperiam, eaque ipsa quae ab illo inventore veritatis et quasi architecto sed ut perspiciatis unde omnis iste natus error sit voluptatem accusantium doloremque laudantium, totam rem aperiam, eaque ipsa quae ab illo inventore veritatis et quasi architecto.